<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB"><gtr:id>F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB</gtr:id><gtr:name>University of Paris Diderot (Paris 7)</gtr:name><gtr:address><gtr:line1>6th European PCRD</gtr:line1><gtr:line2>13 rue Pierre et Marie Curie</gtr:line2><gtr:postCode>F-75205</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20530537-49CC-4FCB-8683-DD28BB737778"><gtr:id>20530537-49CC-4FCB-8683-DD28BB737778</gtr:id><gtr:name>Hospital of the Free University of Brussels</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>School of Life Sciences</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB"><gtr:id>F128C1F3-340C-4C0B-9BD0-93B2CEFF81BB</gtr:id><gtr:name>University of Paris Diderot (Paris 7)</gtr:name><gtr:address><gtr:line1>6th European PCRD</gtr:line1><gtr:line2>13 rue Pierre et Marie Curie</gtr:line2><gtr:postCode>F-75205</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20530537-49CC-4FCB-8683-DD28BB737778"><gtr:id>20530537-49CC-4FCB-8683-DD28BB737778</gtr:id><gtr:name>Hospital of the Free University of Brussels</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6898B2E0-652F-45DF-86EC-524FA18AA3CD"><gtr:id>6898B2E0-652F-45DF-86EC-524FA18AA3CD</gtr:id><gtr:firstName>Tom</gtr:firstName><gtr:surname>Van Agtmael</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601268"><gtr:id>2CEC21D2-5999-46DC-8AD2-C25BD0B3B128</gtr:id><gtr:title>Collagen type IV in vascular biology</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601268</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:technicalSummary>Collagen type IV is the major structural component of the basement membrane, a specialised extracellular matrix structure. In blood vessel walls, this membrane surrounds smooth muscle cells and separates them from endothelial cells. Recently, we have characterised an allelic series of Col4a1 (type IV collagen alpha chain 1) mouse mutants with eye and kidney phenotypes of varying severity. Basement membrane defects in aortae of one of these mutants lead to focal separation of endothelial from smooth muscle cells. A novel role for Col4a1 was identified by functional analysis of aortic endothelial and smooth muscle cells which showed alterations in nitric oxide (NO)-mediated vasodilation due to increased nitric oxide sensitivity. Surprisingly, blood pressure analysis revealed that these animals were hypotensive. 

Aims of the project 
1. Investigation of the molecular consequences of Col4a1 mutations and elucidation of the genotype-phenotype correlation. 
Col4a1 secretion will be analysed to determine whether mutant proteins accumulate in the cell and/or are incorporated in the basement membrane. The consequences of mutant protein retention on cell biology and defective protein incorporation into the basement membrane will be addressed as appropriate. The contribution of these events to the phenotype of Col4a1 mutant animals will be tested. 

2. Analysis of the vascular phenotypes of Col4a1 mutants. 
The effects of col4a1 mutations on NO-dependent and NO-independent vasodilation pathways will be analysed in conduit and resistance vessels. The cause of altered NO sensitivity and mechanism of adaptation in smooth muscle cells will be determined. 

3. Characterisation of the hypotension. 
The hypotension will be analysed to determine whether it is age related, mutation specific and associated with the observed vasodilation abnormalities. 

A combination of mouse genetics, myography, cell culture and molecular biology will be employed to investigate these aims and a collaboration will examine vasodilation in human families with COL4A1 mutations.

In conclusion, this research will provide insight into the mechanism by which Col4a1 mutations affect cell and basement membrane function, the genotype-phenotype correlation of Col4a1 mutants and the role of collagen type IV in vascular tone maintenance. This may identify a general mechanism employed by the vasculature to adapt to altered NO levels and form a paradigm for the role of other basement membrane proteins in vascular biology. Consequently this work will increase our understanding of the pathways and mechanisms of vascular disease.</gtr:technicalSummary><gtr:fund><gtr:end>2010-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>688056</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Wellcome Trust Centre for Cell-Matrix Research</gtr:department><gtr:description>Kadler</gtr:description><gtr:id>1CA76C45-FA97-4C14-8354-B450E9067A1A</gtr:id><gtr:impact>Richardson SH, Al-Youha S, Van Agtmael T, Yeung CC, Zeef L, Lu Y, Ormston VE, Wong J, McGrouther DA, Kadler KE. Tendon is covered by a basement membrane epithelium that is required for cell retention and the prevention of adhesion formation. PLOS One 2011, 6:e16337.</gtr:impact><gtr:outcomeId>myN7xRq1916-1</gtr:outcomeId><gtr:partnerContribution>Establishing in detail the basement membrane defects caused by mutations in collagen type IV via advanced electron microscopy</gtr:partnerContribution><gtr:piContribution>We have characterised the composition of the basement membrane in tendon and analysed the effect of a collagen type IV mutation on the basement membrane in tendon</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INSERM U702 (Remodelling and repair of renal tissue)</gtr:department><gtr:description>Ronco</gtr:description><gtr:id>9B97A4EF-0F40-4431-8A17-C7F076A9EC53</gtr:id><gtr:impact>2 publications</gtr:impact><gtr:outcomeId>9C13E023CED-1</gtr:outcomeId><gtr:partnerContribution>Translation of findings from mouse models to human disease</gtr:partnerContribution><gtr:piContribution>Intellectual input, sharing of data and ideas</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital of the Free University of Brussels</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Department of Medical Genetics</gtr:department><gtr:description>Vilain</gtr:description><gtr:id>DE03B9FC-C58B-427A-9E39-0DADC54237A7</gtr:id><gtr:impact>No outcomes as yet. This collaboration is multi-disciplinary combining clinical research with fundamental science</gtr:impact><gtr:outcomeId>TeWwX14J6Af-1</gtr:outcomeId><gtr:partnerContribution>Collections of patient material including skin biopsies and establishment of primary dermal fibroblasts culture</gtr:partnerContribution><gtr:piContribution>We are utilising the primary dermal fibroblasts to investigate the mechanisms of disease of identified mutations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Paris Diderot University</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Tournier__Lasserve</gtr:description><gtr:id>B6D04360-4B9C-4751-9558-82B043B17907</gtr:id><gtr:impact>Collaboration between clinical and fundamental science. No research output as yet</gtr:impact><gtr:outcomeId>54612c52a32062.38788987-1</gtr:outcomeId><gtr:partnerContribution>Provision of primary dermal fibroblast cultures</gtr:partnerContribution><gtr:piContribution>Functional analysis of collagen IV variants</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Oral presentation Collagen Gordon Conference 2013</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EFF4CBDA-D316-4BC3-BA64-9412BD3183B4</gtr:id><gtr:impact>Talk sparked questions and debate

Following my presentation, received invite for lectures at other Research Institutes in Europe</gtr:impact><gtr:outcomeId>546134c3393745.61302900</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release HMG paper 2013</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5AA1B2F6-C4E9-4F54-B11A-85884AD1D35E</gtr:id><gtr:impact>The Press release was viewed by 101 people in a range of good outlets (including New York Times, Agence France Presse, The Times, Xinhua News Agency). The Herald, The Scotsman and Daily Express wrote an article covering the manuscript.

I received emails from interested groups and inidviduals.</gtr:impact><gtr:outcomeId>XVTpQXpi1ys</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.heraldscotland.com/news/health/stroke-gene-mutation-discovery.22047565,</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>SET for Britain</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D598F420-D8F0-473A-8504-DE84D899D633</gtr:id><gtr:impact>Poster presentation was made to member of parliament.

Increased engagement with our local MPs</gtr:impact><gtr:outcomeId>RtuUdXmcuJh</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Poster Presentation</gtr:presentationType><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>125000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>RCUK Fellowship</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Research Councils UK (RCUK)</gtr:fundingOrg><gtr:id>D93A02C9-42CD-4DD6-B3DD-A3F9553760D8</gtr:id><gtr:outcomeId>qt9v6yNi5ZV0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>16000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Award</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>part of Glasgow DTA award</gtr:fundingRef><gtr:id>F2983E25-3496-4870-B48E-9C1926761A15</gtr:id><gtr:outcomeId>cFuDDWyadK8</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>70000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC PhD-studentship DTA award to Glagow University</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>CDC7BD7E-EB14-4724-BD97-C90BEB9C593E</gtr:id><gtr:outcomeId>WwwoLseAjQE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>135000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Kidney Research UK project grant</gtr:description><gtr:end>2015-02-02</gtr:end><gtr:fundingOrg>Kidney Research UK</gtr:fundingOrg><gtr:fundingRef>RP19/2012</gtr:fundingRef><gtr:id>9C47AC09-C16B-47E4-A67A-8C2B88E79F3D</gtr:id><gtr:outcomeId>fgDZV1y546H</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Summer Studentship</gtr:description><gtr:end>2010-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>FD46E620-DDC6-4AC3-8816-8A5C33331A7B</gtr:id><gtr:outcomeId>ZxStGjxrpnB0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>120000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF PhD studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>EB58992E-5675-4351-A8C1-291F999911D8</gtr:id><gtr:outcomeId>589b1afe7579e7.55857623</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Established primary dermal fibroblast cell culture</gtr:description><gtr:id>883C7644-83F4-4ED6-B8F8-CCCBFA01E4E4</gtr:id><gtr:impact>This will enable us to investigate the disease mechanism using a tissue culture model. This will complement and reduce our animal based studies.</gtr:impact><gtr:outcomeId>jXjbLtoAEAg</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Dermal Primary fibroblasts EW-RW</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>611DFC2D-28D1-492B-9DFF-5650100A7760</gtr:id><gtr:title>Tendon is covered by a basement membrane epithelium that is required for cell retention and the prevention of adhesion formation.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c9fe21cdce04855d9530e0423d36ed30"><gtr:id>c9fe21cdce04855d9530e0423d36ed30</gtr:id><gtr:otherNames>Taylor SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>F150086C_FF150086C_F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D81E51F1-56FA-4F3A-AA4F-1ABC2570BE78</gtr:id><gtr:title>Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b0caae77b9941d7687e458c3c444118"><gtr:id>9b0caae77b9941d7687e458c3c444118</gtr:id><gtr:otherNames>Van Agtmael T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>GeAB4F9uaRw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F84D818A-74CC-4264-85F3-359D6F1CBB7B</gtr:id><gtr:title>Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/519c2166606cb53a24bf4f29c2d4495a"><gtr:id>519c2166606cb53a24bf4f29c2d4495a</gtr:id><gtr:otherNames>Murray LS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14630_20_24001601</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8679B361-E935-4197-812F-5E71D280DCAB</gtr:id><gtr:title>Basement membranes and human disease.</gtr:title><gtr:parentPublicationTitle>Cell and tissue research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9b0caae77b9941d7687e458c3c444118"><gtr:id>9b0caae77b9941d7687e458c3c444118</gtr:id><gtr:otherNames>Van Agtmael T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0302-766X</gtr:issn><gtr:outcomeId>orhHSw76eLY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27189D0C-E667-4089-8246-573A5E10180D</gtr:id><gtr:title>COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ed4f8437e7b85590ed99000e54ddfd9"><gtr:id>0ed4f8437e7b85590ed99000e54ddfd9</gtr:id><gtr:otherNames>Plaisier E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>17C20D37345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27972FB5-9C12-4CB4-9EF2-A98D0D38995B</gtr:id><gtr:title>Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/011bac5ef3ac6810e57a96d02b402124"><gtr:id>011bac5ef3ac6810e57a96d02b402124</gtr:id><gtr:otherNames>Alamowitch S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>r7gaePrYTEX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B47CC886-F730-417C-9E05-7DB7BAE2789F</gtr:id><gtr:title>The Chemical Chaperone, PBA, Reduces ER Stress and Autophagy and Increases Collagen IV a5 Expression in Cultured Fibroblasts From Men With X-Linked Alport Syndrome and Missense Mutations.</gtr:title><gtr:parentPublicationTitle>Kidney international reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a0385ddf822030de0fee889762bbc89e"><gtr:id>a0385ddf822030de0fee889762bbc89e</gtr:id><gtr:otherNames>Wang D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2468-0249</gtr:issn><gtr:outcomeId>5a9ff5ae8cdf65.59072172</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F6F6A1A-052F-47EA-AE1E-1D537CE60EEC</gtr:id><gtr:title>ER stress and basement membrane defects combine to cause glomerular and tubular renal disease resulting from Col4a1 mutations in mice.</gtr:title><gtr:parentPublicationTitle>Disease models &amp; mechanisms</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95136a8134172afd9d87069b353a9625"><gtr:id>95136a8134172afd9d87069b353a9625</gtr:id><gtr:otherNames>Jones FE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1754-8403</gtr:issn><gtr:outcomeId>56bcc664a86777.53760653</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601268</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>